Applications of HVLD in Pharmaceutical Manufacturing

Pharmaceutical manufacturing involves extensive quality activities throughout product development, validation, commercial production, storage, and distribution. As injectable drugs, biologics, vaccines, and combination products become increasingly sophisticated, packaging systems are expected to perform consistently throughout their intended shelf life. Even small defects within a container or closure system can create pathways for contamination ingress, moisture penetration, or product leakage, potentially affecting product quality.

Package integrity inspection programs are therefore implemented at multiple stages of the product lifecycle. Inspection activities may occur during package development, process qualification, routine manufacturing, stability studies, and quality investigations. Modern inspection methods generate measurable data that supports packaging evaluations while identifying defects that may not be visible through conventional visual inspection techniques.

Among the inspection technologies used with liquid-filled pharmaceutical products, High Voltage Leak Detection (HVLD) has gained significant adoption due to its sensitivity, repeatability, and compatibility with a variety of packaging formats.

Overview of HVLD Technology

High Voltage Leak Detection (HVLD) is a non-destructive Container Closure Integrity Testing (CCIT) method used primarily for liquid-filled pharmaceutical packaging, specifically parenteral products. The technology applies a controlled high-voltage, low-current electrical signal across a package while monitoring changes in conductivity.

When a container is intact, the electrical signal follows a predictable path through the package. Defects such as pinholes, cracks, microfractures, or seal imperfections alter this pathway, creating measurable changes in the electrical characteristics detected by the system. These changes allow identification of defects that may not be visible during visual inspection.

HVLD is particularly suitable for products containing conductive or semi-conductive liquids. Because many injectable drug products exhibit these characteristics, the technology is frequently used within pharmaceutical manufacturing environments. The method generates objective inspection results and can be configured for a variety of container types, closure systems, and production requirements.

Inline and Offline Inspection Capabilities

One of the advantages of HVLD technology is its flexibility within different manufacturing workflows. The technology can be implemented as either an inline inspection solution or an offline laboratory testing method.

In inline applications, HVLD systems are integrated directly into production lines, allowing containers to be inspected as they move through manufacturing processes. Automated inspection enables high-throughput evaluation while generating consistent inspection data across large production batches.

Offline testing is often performed during package development activities, process qualification studies, method validation programs, and investigation activities. Laboratory-based evaluations provide manufacturers with additional insight into package performance under controlled testing conditions.

The availability of both inline and offline configurations allows manufacturers to apply a common inspection technology across multiple stages of the product lifecycle while maintaining consistency in testing methodology.

Applications in Liquid-Filled Containers

HVLD technology is applied across a broad range of liquid-filled pharmaceutical packaging formats. Its sensitivity to conductivity changes makes it particularly effective for containers holding aqueous formulations and injectable products.

Common applications include:

• Injectable drug vials
• Ampoules
• Prefilled syringes
• Cartridges
• Blow-fill-seal (BFS) containers
• Ophthalmic packaging systems
• Biologic drug products
• Vaccine containers

Within these packaging formats, HVLD can identify defects such as glass cracks, pinholes, seal imperfections, incomplete closures, and other integrity-related issues.

The technology is often incorporated into package development studies, process validation activities, manufacturing inspections, and quality investigations. Its ability to inspect containers without damaging the product allows additional evaluations to be performed on the same samples when required.

Benefits of HVLD Technology

HVLD offers several advantages for pharmaceutical manufacturing applications.

• High level of repeatability and precision
• Deterministic, non-destructive, non-invasive
• Product and environmental low voltage exposure
• Offline and 100% online testing at high production speeds
• Simpler inspection and validation procedure
• Robust method and approximate 3x Signal-Noise-Ratio for a wide range of product classes and package formats
• Effective in all parenteral preparations, even liquids with extremely low conductivity.

Conclusion

HVLD has become an established inspection method for liquid-filled pharmaceutical packaging across development, validation, and manufacturing activities. Through conductivity-based measurements, the technology can identify defects such as cracks, pinholes, microfractures, and closure imperfections while generating objective and repeatable inspection data.

Applications spanning injectable vials, ampoules, prefilled syringes, cartridges, blow-fill-seal containers, and ophthalmic packaging demonstrate the versatility of the technology within pharmaceutical operations. The availability of both inline and offline configurations further expands its use across multiple stages of the product lifecycle.

As pharmaceutical packaging systems become more sophisticated and quality expectations evolve, HVLD provides manufacturers with a reliable approach for package integrity inspection, defect identification, and quantitative performance evaluation across a broad range of liquid-filled packaging formats.

Frequently Asked Questions

1. What types of defects can HVLD identify in pharmaceutical packaging?

A. HVLD can identify defects such as pinholes, cracks, microfractures, seal imperfections, incomplete closures, and other integrity-related issues in liquid-filled pharmaceutical containers. The technology detects changes in electrical conductivity caused by these defects, allowing identification of leak pathways that may not be visible during visual inspection.

2. Can HVLD be used for both production-line and laboratory testing?

A. Yes. HVLD can be implemented as an inline inspection system for high-speed production environments or as an offline laboratory method for package development, process qualification, validation studies, and quality investigations. This flexibility allows the same inspection approach to be applied across multiple stages of the product lifecycle.

3. Which pharmaceutical packaging formats are suitable for HVLD testing?

A. HVLD is suitable for a variety of liquid-filled pharmaceutical packaging formats, including injectable vials, ampoules, prefilled syringes, cartridges, blow-fill-seal (BFS) containers, ophthalmic packaging systems, biologic drug products, and vaccine containers. It is particularly effective for packages containing conductive or semi-conductive liquid formulations.